JW (CAYMAN) THERAPEUTICS CO. LTD

Press Releases JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Delayed Hong Kong S.E. Other stock markets 11:58:05 2024-04-29 pm EDT			5-day change	1st Jan Change
1.83 ^HKD	+0.55%		+4.57%	-19.03%

Mar. 20	JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023	MT
Mar. 20	JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

WuXi Giant Nuo Announces Initiation of Clinical Study of JWATM214 for the Treatment of Advanced Hepatocellular Carcinoma	23-03-01	AQ
Medigene Receives $3 Million Milestone Payment from 2seventy bio	23-01-18	AQ
JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma	22-07-04	AQ
JW Therapeutics Announces IND Approval for the Pivotal Clinical Trial of Carteyva® in Second-line Large B-Cell Lymphoma	22-03-31	PR
JW Cayman Therapeutics : Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China	21-09-06	AQ
JW Therapeutics : Announces Strategic Partnership with MediTrust Health	21-08-20	PR
JW Cayman Therapeutics : CHANGE OF COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT	21-07-30	PU
JW Cayman Therapeutics : Form of proxy for the Annual General Meeting to be held on May 26, 2021	21-04-23	PU
JW Cayman Therapeutics : PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING	21-04-23	PU
JW Cayman Therapeutics : VOLUNTARY ANNOUNCEMENT - INCLUSION OF THE SHARES OF THE COMPANY IN THE HONG KONG STOCK CONNECT LIST UNDER THE SHENZHEN-HONG KONG STOCK CONNECT	21-03-15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer